ACR DSI releases 1st AI use cases seeking feedback

The American College of Radiology Data Science Institute (ACR DSI) released its first use cases from the TOUCH-AI library for industry comment to gain feedback before the entire library of use cases are released this fall, according to an ACR release.

DSI has reached out to a variety of societies and organizations which specialize in artificial intelligence (AI), analytics, reporting systems, electronic medical record (EMR) and picture archive and communication systems (PACS). All groups currently developing or supporting AI in radiology are welcome to submit feedback.

Use cases will be available for free from the ACR DSI TOUCH-AI library this fall and will outline a path on where AI can advance patient care for vendors, clinicians and patients.  

“As we are working to obtain and incorporate feedback into our preliminary use cases, we are seeing a groundswell of support for the information we are providing,” said Laura Coombs, ACR Senior Director of Informatics, in the statement. “This is an exciting stage of use case development because every bit of feedback, no matter how small, has the potential to profoundly affect both the industry and clinicians’ ability to create and deploy AI technology.”

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.